These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 31886230)
1. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer. Shu J; Wang L; Han F; Chen Y; Wang S; Luo F Biomed Res Int; 2019; 2019():5937635. PubMed ID: 31886230 [TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4. Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541 [TBL] [Abstract][Full Text] [Related]
3. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation. Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789 [TBL] [Abstract][Full Text] [Related]
4. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
6. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma. Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874 [TBL] [Abstract][Full Text] [Related]
7. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium. Park IH; Kang JH; Shin JM; Lee HM PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418 [TBL] [Abstract][Full Text] [Related]
8. Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer. Fan C; Miao Y; Zhang X; Liu D; Jiang G; Lin X; Han Q; Luan L; Xu Z; Wang E BMC Cancer; 2014 Sep; 14():704. PubMed ID: 25253020 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679 [TBL] [Abstract][Full Text] [Related]
10. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells. Feng H; Lu JJ; Wang Y; Pei L; Chen X Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373 [TBL] [Abstract][Full Text] [Related]
11. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma. Yang L; Wang T; Zhang J; Wang X Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition. Li J; Yang S; Yan W; Yang J; Qin YJ; Lin XL; Xie RY; Wang SC; Jin W; Gao F; Shi JW; Zhao WT; Jia JS; Shen HF; Ke JR; Liu B; Zhao YQ; Huang WH; Yao KT; Li DJ; Xiao D Lab Invest; 2015 Sep; 95(9):1056-70. PubMed ID: 26098000 [TBL] [Abstract][Full Text] [Related]
13. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway. Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428 [TBL] [Abstract][Full Text] [Related]
14. TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer. Khan GJ; Gao Y; Gu M; Wang L; Khan S; Naeem F; Semukunzi H; Roy D; Yuan S; Sun L Curr Cancer Drug Targets; 2018; 18(2):209-219. PubMed ID: 28782471 [TBL] [Abstract][Full Text] [Related]
15. Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of Wang JS; Wang MJ; Lu X; Zhang J; Liu QX; Zhou D; Dai JG; Zheng H Bioengineered; 2020 Dec; 11(1):1197-1207. PubMed ID: 33108235 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
17. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer]. Wei L; Qin XP; Zhao XX; Wang W Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173 [No Abstract] [Full Text] [Related]
18. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo. He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132 [TBL] [Abstract][Full Text] [Related]
20. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin. Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]